Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Cancer, Lipids, and Metabolism, and Epigenetics and DNA Methylation.
Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer: Call for a Multidisciplinary Approach
International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1
Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer
Cellular senescence in precancer lesions and early-stage cancers
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial
Defining precancer: a grand challenge for the cancer community
Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer
Predicting prostate cancer grade reclassification on active surveillance using a deep learning–based grading algorithm
Predicting Prostate Cancer Molecular Subtype With Deep Learning on Histopathologic Images
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer
Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary Prostate Cancer with Prostate-Specific Membrane Antigen–Targeted<sup>18</sup>F-DCFPyL PET/CT
SOX2 mediates metabolic reprogramming of prostate cancer cells
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression
Genomic and phenotypic heterogeneity in prostate cancer
The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer
Prostate carcinogenesis: inflammatory storms
Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance
Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
Differential mast cell phenotypes in benign versus cancer tissues and prostate cancer oncologic outcomes
Cancer overdiagnosis: a biological challenge and clinical dilemma
<i>Trichomonas vaginalis</i> infection and prostate‐specific antigen concentration: Insights into prostate involvement and prostate disease risk
Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate
Clinical implications of PTEN loss in prostate cancer
Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer
Eosinophilic Solid and Cystic (ESC) Renal Cell Carcinomas Harbor TSC Mutations
Redox‐Responsive Nanoparticle‐Mediated Systemic RNAi for Effective Cancer Therapy
MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease